Toledo, Rodrigo A.; Hatakana, Roxanne; Lourenço Jr, Delmar M.; Lindsey, Susan C.; Camacho, Cleber P.; Almeida, Marcio; Lima Jr, José V.; Sekiya, Tomoko; Garralda, Elena; Naslavsky, Michel 
; Yamamoto, Guilherme L.; Lazar, Monize; Meirelles, Osorio; Sobreira, Tiago J. P.; Lebrao, Maria Lucia; Duarte, Yeda Aparecida de Oliveira ; Blangero, John; Zatz, Mayana ; Cerutti, Janete M.; Maciel, Rui M. B.; Toledo, Sergio P. A.
Fonte: Endocrine - Related Cancer. Unidades: FSP, EE, IB, FM
Assuntos: NEOPLASIA ENDÓCRINA MÚLTIPLA, PROTO-ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOLEDO, Rodrigo A. et al. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocrine - Related Cancer, v. 22, n. 2, 2015Tradução . . Disponível em: https://doi.org/10.1530/ERC-14-0491. Acesso em: 02 ago. 2024.APA
Toledo, R. A., Hatakana, R., Lourenço Jr, D. M., Lindsey, S. C., Camacho, C. P., Almeida, M., et al. (2015). Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility. Endocrine - Related Cancer, 22( 2). doi:10.1530/ERC-14-0491NLM
Toledo RA, Hatakana R, Lourenço Jr DM, Lindsey SC, Camacho CP, Almeida M, Lima Jr JV, Sekiya T, Garralda E, Naslavsky M, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJP, Lebrao ML, Duarte YA de O, Blangero J, Zatz M, Cerutti JM, Maciel RMB, Toledo SPA. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility [Internet]. Endocrine - Related Cancer. 2015 ; 22( 2):[citado 2024 ago. 02 ] Available from: https://doi.org/10.1530/ERC-14-0491Vancouver
Toledo RA, Hatakana R, Lourenço Jr DM, Lindsey SC, Camacho CP, Almeida M, Lima Jr JV, Sekiya T, Garralda E, Naslavsky M, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJP, Lebrao ML, Duarte YA de O, Blangero J, Zatz M, Cerutti JM, Maciel RMB, Toledo SPA. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility [Internet]. Endocrine - Related Cancer. 2015 ; 22( 2):[citado 2024 ago. 02 ] Available from: https://doi.org/10.1530/ERC-14-0491
